Ectoin Dermatitis Cream 7% as First-line Therapy of Acute Skin Graft Versus Host Disease

A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema

NCT05259722 ·Status: COMPLETED ·Phase: PHASE3

Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis

NCT02369432 ·Status: TERMINATED ·Phase: EARLY_PHASE1

Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema

NCT04871711 ·Status: COMPLETED ·Phase: PHASE3

Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema

NCT03683719 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)

NCT04872101 ·Status: COMPLETED ·Phase: PHASE3

Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel

NCT05253755 ·Status: TERMINATED ·Phase: PHASE2

A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo

NCT01299610 ·Status: COMPLETED ·Phase: PHASE2

Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis

NCT00354510 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.

NCT06756438 ·Status: RECRUITING ·Phase: NA

Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis

NCT02118792 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Efficacy of a Dermocosmetic Product RT00401-GO0046 on Atopic Dermititis Severity in Subjects With Mild Atopic Dermatitis Versus Placebo

NCT06763939 ·Status: COMPLETED

Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis

NCT03736967 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis

NCT03089229 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Skin Irritation Study of GSK2894512 Cream

NCT02637206 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate JAK Inhibitor Cream in EGFR-inhibitor-induced Skin Rash

NCT05120362 ·Status: UNKNOWN ·Phase: NA

Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients

NCT02144142 ·Status: WITHDRAWN ·Phase: PHASE2

Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD)

NCT02925793 ·Status: COMPLETED ·Phase: PHASE2

Immunopharmacological Effects of Rituximab in Atopic Dermatitis

NCT00267826 ·Status: COMPLETED ·Phase: NA

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

NCT07290803 ·Status: RECRUITING

8-Week Atopic Dermatitis (AD) Treatment Study

NCT03386032 ·Status: COMPLETED ·Phase: PHASE3

Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis

NCT04753034 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.

NCT01447758 ·Status: TERMINATED ·Phase: PHASE1

CT 327 in the Treatment of Atopic Dermatitis

NCT00996008 ·Status: TERMINATED ·Phase: PHASE2

Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms

NCT06268847 ·Status: COMPLETED ·Phase: NA

Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis

NCT01792713 ·Status: COMPLETED ·Phase: PHASE2